跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Symdex-D - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Symdex-D
Approved
STANDARD
Symdex-D
Allied Pharmaceutical Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d088ae58b598f28b
Company
Allied Pharmaceutical Laboratories Inc.
Type
Standard
Approval Details
Approval Id
d088ae58b598f28b
Drug Approval Philippines Name
Symdex-D
Product Name
Symdex-D
Registration Number
DR-XY47810
Brand Name
Symdex-D
Generic Name
Paracetamol + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
Dosage Form
Tablet
Dosage Strength
325 mg/25 mg/2 mg
Manufacturer
Allied Pharmaceutical Laboratories Inc.
Issuance Date
28 April 2022
Expiry Date
16 March 2027
Pharmacologic Category
Analgesic/Antipyretic/Nasal Decongestant/Antihistamine
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d088ae58b598f28b
Type
Standard
Back to Philippines FDA Approvals